Your institution may have access to this item. Find your institution then sign in to continue.
Title
Improving the efficacy of antibody-based cancer therapies.
Authors
Carter, P
Abstract
A quarter of a century after their advent, monoclonal antibodies have become the most rapidly expanding class of pharmaceuticals for treating a wide variety of human diseases, including cancer. Although antibodies have yet to achieve the ultimate goal of curing cancer, many innovative approaches stand poised to improve the efficacy of antibody-based therapies.